Arlington Trust Co LLC Sells 2,113 Shares of Eli Lilly and Company $LLY

robot
Abstract generation in progress

Arlington Trust Co LLC significantly reduced its stake in Eli Lilly and Company (LLY) by selling 2,113 shares, decreasing its position by 92.8% in the fourth quarter. Despite this, other institutional investors increased their holdings, and the company reported strong Q1 earnings, beating consensus estimates with revenue of $19.80 billion and an EPS of $8.55. Eli Lilly also raised its annual profit forecast, driven by the success of its GLP-1 drugs and a positive regulatory environment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin